ASS1 and malignant pleural mesothelioma: In the treatment of ASS1‐deficient cutaneous melanoma, uveal melanoma, and malignant pleural mesothelioma, ADI‐PEG 20 was well tolerated and demonstrated antitumor activity.9, 10, 23, 24